EBV-positive patients typically exhibit intact MYC due to alternative oncogenic factors such as JAK-STAT activation, whereas myeloma-like MYC-driven aggressive metabolism often prevails in EBV-negative PBL [44,45]. Here, MYC is linked to plasma cell myeloma.